-
Arachidonic Acid as a Dietary Adjuvant for Humoral Immunity
2026-09-19
The reference study shows that dietary arachidonic acid enhances rabies vaccine–induced neutralizing antibodies and improves protection against lethal rabies virus infection in mice. Its integrated mouse, human, and mechanistic data identify lymph-node lipid metabolism and a PGI2–cAMP–PKA pathway as potential links between nutrition and germinal-center B-cell responses.
-
Glucagon–GLP-1R Crosstalk in FRET cAMP Assays
2026-09-19
Chepurny and colleagues used high-throughput FRET measurements of cAMP, pharmacological probes, cellular validation, and molecular modeling to show that glucagon can activate the GLP-1 receptor under defined experimental conditions. The findings expose clinically relevant receptor promiscuity and provide a framework for interpreting antagonist selectivity and designing multi-receptor peptide agonists.
-
MTT Assay Reliability: A Practical Lab Guide
2026-09-18
Learn how MTT and SKU B7777 can improve interpretation, reagent handling, and reproducibility in cell viability and proliferation workflows. This scenario-based guide connects assay chemistry with practical controls, optimization, and evidence-based vendor selection.
-
WST-8 Glucose Uptake Assay: Workflow & Uses
2026-09-18
The WST-8 Glucose Uptake Assay Kit provides a non-radioactive route to quantify functional glucose handling in cultured cells. This guide connects practical assay execution with ion-modulated nucleic acid delivery, cancer metabolism research, and diabetes-focused experimental design.
-
TRPV1 and TRPA1 Decode Distinct ROS Signals
2026-09-17
A 2026 Redox Biology study shows that TRPV1 and TRPA1 distinguish singlet oxygen from hydrogen peroxide rather than treating both as equivalent oxidative stimuli. Electrophysiology, calcium imaging, and residue-focused analysis reveal channel-specific responses that clarify how ROS identity and agonist state shape TRP-channel signaling.
-
Anlotinib hydrochloride: Angiogenesis Assay Workflows
2026-09-17
Anlotinib hydrochloride supports mechanism-led studies of endothelial migration, capillary morphogenesis, receptor phosphorylation, and ERK pathway activity. This guide converts multi-target inhibition data and a rare-tumor case report into practical assay workflows, controls, and troubleshooting decisions for cancer research.
-
Gemcitabine Workflows for DNA Damage Research
2026-09-16
Build reproducible Gemcitabine experiments that connect DNA synthesis inhibition with checkpoint activation, apoptosis, and proliferation control. This practical workflow also shows how transcriptomics-inspired metabolic readouts can extend, but not replace, conventional DNA damage response assays.
-
D-Luciferin Sodium Salt for CAR-M Imaging
2026-09-15
D-Luciferin sodium salt enables ATP-dependent bioluminescence assays for studying engineered immune cells. This article explains how to interpret firefly luciferase signals in CAR-macrophage research and translate recent immunotherapy findings into more rigorous imaging workflows.
-
Sulfamonomethoxine Toxicity in Aquatic Trophic Levels
2026-09-15
Huang and colleagues compared sulfamonomethoxine toxicity across algae and cladocerans using acute and chronic bioassays, showing that microalgae were more sensitive than the tested crustaceans. The study provides a useful framework for interpreting antibiotic residues in aquaculture-impacted water while emphasizing that species, exposure duration, and endpoint selection strongly influence ecological risk estimates.
-
Medroxyprogesterone acetate: Assay Guide
2026-09-14
This scenario-based guide explains how Medroxyprogesterone acetate (SKU B1510) can support reproducible viability, proliferation, cytotoxicity, renal, and decidualization workflows. It connects solvent handling, dose interpretation, assay controls, and vendor selection to current mechanistic evidence.
-
SGI-1027 and Apoptosis in Huh7 Liver Cancer Cells
2026-09-14
The reference study shows that the non-nucleoside DNMT inhibitor SGI-1027 reduces Huh7 hepatocellular carcinoma cell viability and promotes apoptosis without substantially changing cell-cycle distribution. Its combination of viability, flow-cytometric, TUNEL, and immunoblot analyses supports a mitochondrial apoptosis model while also defining important limits for translation beyond this in vitro system.
-
Regorafenib: From Kinase Network to Melanoma
2026-09-13
Regorafenib (BAY 73-4506) offers a mechanism-first platform for connecting angiogenic, stromal, and tumor-intrinsic signaling with translational oncology decisions. This article interprets the RRM2–ERK/E2F3 melanoma findings alongside practical assay design, biomarker strategy, and tumor xenograft planning.
-
Measuring Drug Response Beyond Relative Viability
2026-09-12
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer drug response. Its central contribution is a framework for separating proliferative arrest from cell killing, improving interpretation of in vitro drug-response experiments and the design of follow-up assays.
-
Carvedilol in β-Adrenergic Receptor Research
2026-09-12
Carvedilol is a nonselective β-adrenergic receptor antagonist that links cardiovascular signaling, oxidative stress inhibition, vascular remodeling, and hematopoietic regeneration assays. Its use-case advantage is the ability to interrogate combined β- and α1-adrenergic blockade, while recent transplant findings show why receptor selectivity and experimental timing must be controlled.
-
Tofacitinib Citrate: Reliable Assay Workflows
2026-09-11
This scenario-based guide explains how Tofacitinib citrate (CP-690550 citrate), SKU A4135, can improve experimental control in immune-cell proliferation, differentiation, viability, and inflammatory signaling assays. It integrates formulation data with concentration-aware interpretation of recent endothelial-cell findings.